Artificial intelligence at the national eye institute.


Journal

Current opinion in ophthalmology
ISSN: 1531-7021
Titre abrégé: Curr Opin Ophthalmol
Pays: United States
ID NLM: 9011108

Informations de publication

Date de publication:
01 Nov 2022
Historique:
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 12 10 2022
Statut: ppublish

Résumé

This review highlights the artificial intelligence, machine learning, and deep learning initiatives supported by the National Institutes of Health (NIH) and the National Eye Institute (NEI) and calls attention to activities and goals defined in the NEI Strategic Plan as well as opportunities for future activities and breakthroughs in ophthalmology. Ophthalmology is at the forefront of artificial intelligence-based innovations in biomedical research that may lead to improvement in early detection and surveillance of ocular disease, prediction of progression, and improved quality of life. Technological advances have ushered in an era where unprecedented amounts of information can be linked that enable scientific discovery. However, there remains an unmet need to collect, harmonize, and share data in a machine actionable manner. Similarly, there is a need to ensure that efforts promote health and research equity by expanding diversity in the data and workforce. The NIH/NEI has supported the development artificial intelligence-based innovations to advance biomedical research. The NIH/NEI has defined activities to achieve these goals in the NIH Strategic Plan for Data Science and the NEI Strategic Plan and have spearheaded initiatives to facilitate research in these areas.

Identifiants

pubmed: 36206110
doi: 10.1097/ICU.0000000000000889
pii: 00055735-202211000-00017
pmc: PMC9555870
mid: NIHMS1817529
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-584

Subventions

Organisme : Intramural NIH HHS
ID : Z99 EY999999
Pays : United States

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

NIH releases strategic plan for data science. (2018, June 4). National Institutes of Health, News Releases. Retrieved March 6, 2022 from https://www.nih.gov/news-events/news-releases/nih-releases-strategic-plan-data-science
NEI Strategic Plan: Vision for the Future [Internet]. 2021. Available from: Strategic Planning at NEI. (2021, November 1). National Eye Institute. Retrieved March 7, 2022 from https://www.nei.nih.gov/about/strategic-planning
ACD Working Group on Artificial Intelligence. (2019, January 29). National Institutes of Health, Advisory Committee to the Director. Retrieved March 7, 2022 from https://www.acd.od.nih.gov/working-groups/ai.html
Bridge to Artificial Intelligence (Bridge2AI). (2022, May 24). National Institutes of Health, Common Fund Programs. Retrieved June 10, 2022 from https://commonfund.nih.gov/bridge2ai
About the Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity (AIM-AHEAD) Program. (2021, October 6). National Institutes of Health, Office of Data Science Strategy. Retrieved March 7, 2022 from https://datascience.nih.gov/artificial-intelligence/aim-ahead
Diaz-Pinto A, Ravikumar N, Attar R, et al. Predicting myocardial infarction through retinal scans and minimal personal information. Nat Mach Intell 2022; 4:55–61.
Schaefer J, Lehne M, Schepers J, et al. The use of machine learning in rare diseases: a scoping review. Orphanet J Rare Dis 2020; 15:145.
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. (2018, April 11). U.S. Food and Drug Administration, News Release. Retrieved March 7, 2022 from https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye
Tech that detects cause of preemie blindness gets federal nod. (2020, January 30). National Eye Institute, NEI Research News. Retrieved March 7, 2022 from https://www.nei.nih.gov/about/news-and-events/news/tech-detects-cause-preemie-blindness-gets-federal-nod
Sharma R, George A, Nimmagadda M, et al. Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. Nat Commun 2021; 12:7293.
Farnum A, Pelled G. New vision for visual prostheses. Front Neurosci 2020; 14:36.
Liu Y, Holekamp NLM, Heier JS. Prospective, longitudinal study: daily self-imaging with home OCT in neovascular age-related macular degeneration. Ophthalmol Retina 2022; S2468653022000732. doi: 10.1016/j.oret.2022.02.011. Epub ahead of print.
doi: 10.1016/j.oret.2022.02.011.
Duke Researchers Launch NIH-funded Study to Compare NGoggle with Conventional Glaucoma Detection Methods. (2019, February 5). NEI News Brief. Retrieved April 5, 2022 from https://dukeeyecenter.duke.edu/news-events/duke-researchers-launch-nih-funded-study-compare-ngoggle-conventional-glaucoma-detection
Mariottoni EB, Jammal AA, Berchuck SI, et al. An objective structural and functional reference standard in glaucoma. Sci Rep 2021; 11:1752.
Feng PW, Ahluwalia A, Feng H, Adelman RA. National trends in the United States Eye Care Workforce from 1995 to 2017. Am J Ophthalmol 2020; 218:128–135.
Allison K, Patel D, Besharim C. The value of annual glaucoma screening for high-risk adults ages 60 to 80. Cureus [Internet] 2021; 13:e18710.
Limwattanayingyong J, Nganthavee V, Seresirikachorn K, et al. Longitudinal screening for diabetic retinopathy in a nationwide screening program: comparing deep learning and human graders. Reverter JL, editor. J Diabetes Res 2020; 2020:1–8.
Zhang H, Jin L, Ye C. An RGB-D camera based visual positioning system for assistive navigation by a robotic navigation aid. IEEECAA J Autom Sin 2021; 8:1389–1400.
Institute and Center Funded Initiatives. (2021, July 15). National Institutes of Health, Office of Data Science Strategy, Artificial Intelligence. Retrieved March 6, 2022 from https://datascience.nih.gov/artificial-intelligence/institute-and-center-funded-initiatives
About the Administrative Supplements for Workforce Development at the Interface of Information Sciences, Artificial Intelligence and Machine Learning (AI/ML), and Biomedical Sciences. (2022, February 9). National Institutes of Health, Office of Data Science Strategy. Retrieved March 7, 2022 from https://datascience.nih.gov/artificial-intelligence/initiatives/Workforce-Gap-Data-Governance-AI
Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data 2016; 3:160018.

Auteurs

Noha A Sherif (NA)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Emily Y Chew (EY)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Michael F Chiang (MF)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Michelle Hribar (M)

Oregon Health & Science University, Portland, Oregon, USA.

James Gao (J)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Kerry E Goetz (KE)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH